作者
Bruno Guy, Farshad Guirakhoo, Veronique Barban, Stephen Higgs, Thomas P Monath, Jean Lang
发表日期
2010/1/8
来源
Vaccine
卷号
28
期号
3
页码范围
632-649
出版商
Elsevier
简介
Dengue viruses (DENV), West Nile virus (WNV) and Japanese encephalitis virus (JEV) are major global health and growing medical problems. While a live-attenuated vaccine exists since decades against the prototype flavivirus, yellow fever virus (YFV), there is an urgent need for vaccines against dengue or West Nile diseases, and for improved vaccines against Japanese encephalitis. Live-attenuated chimeric viruses were constructed by replacing the genes coding for Premembrane (prM) and Envelope (E) proteins from YFV 17D vaccine strain with those of heterologous flaviviruses (ChimeriVax™ technology). This technology has been used to produce vaccine candidates for humans, for construction of a horse vaccine for West Nile fever, and as diagnostic reagents for dengue, Japanese encephalitis, West Nile and St. Louis encephalitis infections. This review focuses on human vaccines and their …
引用总数
20102011201220132014201520162017201820192020202120222023202428373533282420191721212014122